Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 14/20 | 0.49 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.36 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.36 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.36 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.35 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.35 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.34 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27899116 | 1.00 | DPP4 (0.49) | DPP4SLC1A1KCNH2SLC1A3SLC1A2 | |
| SCHEMBL11221173 | 1.00 | DPP4 (0.49) | DPP4SLC1A1KCNH2SLC1A3SLC1A2 | |
| SCHEMBL6032240 | 0.89 | DPP4 (0.39) | DPP4SLC1A1SLC1A3SLC1A2SLC7A5 | |
| SCHEMBL27670609 | 0.83 | CTSS (0.47) | SLC1A1SLC1A3SLC1A2SLC7A5 | |
| SCHEMBL21924972 | 0.83 | DPP4 (0.50) | DPP4KCNH2SLC7A5DPP7DPP8 | |
| SCHEMBL3453798 | 0.83 | DPP4 (0.50) | DPP4KCNH2SLC7A5DPP7DPP8 | |
| SCHEMBL27899115 | 0.81 | DPP4 (0.46) | DPP4KCNH2DPP7DPP8DPP9 | |
| SCHEMBL29580049 | 0.79 | DPP4 (0.45) | DPP4SLC1A1SLC1A3SLC1A2DPP7 | |
| SCHEMBL28937623 | 0.79 | DPP4 (0.45) | DPP4SLC1A1SLC1A3SLC1A2DPP7 | |
| SCHEMBL17513199 | 0.77 | SLC1A1 (0.48) | SLC1A1SLC1A3SLC1A2SLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105294479-A | Preparation method of 3R-amino substituted butyrylamide derivative | XINFA PHARMACEUTICAL CO LTD | 2016-02-03 | — | — | CN | disclosed |